- Zacks•9 hours ago
Value investing is easily one of the most popular ways to find great stocks in any market environment.
- PR Newswire•12 hours ago
Shire plc (LSE: SHP, NASDAQ: SHPG) announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the Class 2 resubmission of a New Drug Application (NDA) for SHP465, a long-acting, triple-bead, mixed amphetamine salts formulation. SHP465 is being evaluated as a potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is expected to provide a decision on or around June 20, 2017, the designated Prescription Drug User Fee Act (PDUFA) action date.
- MarketWatch•6 days ago
U.K. stocks gained for a 14th straight day on Friday, extending their record winning run as a soft pound helped spur investors to buy into British multinationals.
SHPG : Summary for Shire plc - American Depositary - Yahoo Finance
Shire plc (SHPG)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||164.11 x 100|
|Ask||176.99 x 200|
|Day's Range||163.75 - 166.20|
|52 Week Range||161.55 - 209.22|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||250.93|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|